Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.

Browning DJ.

Am J Ophthalmol. 2013 Mar;155(3):418-428.e1. doi: 10.1016/j.ajo.2012.09.025. Epub 2012 Dec 4.

PMID:
23218706
2.

Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.

Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology..

Ophthalmology. 2011 Feb;118(2):415-22. doi: 10.1016/j.ophtha.2010.11.017.

PMID:
21292109
3.

Hydroxychloroquine screening practice patterns within a large multispecialty ophthalmic practice.

Au A, Parikh V, Modi YS, Ehlers JP, Schachat AP, Singh RP.

Am J Ophthalmol. 2015 Sep;160(3):561-568.e2. doi: 10.1016/j.ajo.2015.06.009. Epub 2015 Jun 24.

PMID:
26116260
4.

Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.

Lyons JS.

Am J Ophthalmol. 2013 Aug;156(2):410. doi: 10.1016/j.ajo.2013.04.012. No abstract available.

PMID:
23870365
5.

AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.

McClellan AJ, Chang JS, Smiddy WE.

Retina. 2016 Oct;36(10):1958-63. doi: 10.1097/IAE.0000000000001235.

PMID:
27465574
6.

Subjective and objective screening tests for hydroxychloroquine toxicity.

Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL 3rd, Sieving PA.

Ophthalmology. 2015 Feb;122(2):356-66. doi: 10.1016/j.ophtha.2014.07.056. Epub 2014 Oct 14.

PMID:
25444344
7.

Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.

Lyons JS, Severns ML.

Am J Ophthalmol. 2007 May;143(5):801-809. Epub 2007 Mar 6.

PMID:
17336914
8.

Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.

Marmor MF, Melles RB.

Ophthalmology. 2014 Jun;121(6):1257-62. doi: 10.1016/j.ophtha.2013.12.002. Epub 2014 Jan 16.

PMID:
24439759
9.

Efficient and effective screening for hydroxychloroquine toxicity.

Marmor MF.

Am J Ophthalmol. 2013 Mar;155(3):413-4. doi: 10.1016/j.ajo.2012.10.020. No abstract available.

PMID:
23394729
10.

Comparison of screening procedures in hydroxychloroquine toxicity.

Marmor MF.

Arch Ophthalmol. 2012 Apr;130(4):461-9. doi: 10.1001/archophthalmol.2011.371. Epub 2011 Dec 12.

PMID:
22159170
11.

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF; American Academy of Ophthalmology..

Ophthalmology. 2002 Jul;109(7):1377-82. No abstract available.

PMID:
12093666
12.

Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.

Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.

JAMA Ophthalmol. 2013 Sep;131(9):1187-97. doi: 10.1001/jamaophthalmol.2013.4244.

PMID:
23887202
13.

New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.

Marmor MF.

Arthritis Rheum. 2003 Jun;48(6):1764. No abstract available.

14.

Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.

Leung LS, Neal JW, Wakelee HA, Sequist LV, Marmor MF.

Am J Ophthalmol. 2015 Oct;160(4):799-805.e1. doi: 10.1016/j.ajo.2015.07.012. Epub 2015 Jul 17.

PMID:
26189086
15.

Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.

Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG.

Ophthalmology. 2015 Jun;122(6):1239-1251.e4. doi: 10.1016/j.ophtha.2015.02.011. Epub 2015 Mar 29. Review.

PMID:
25824328
16.

The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M.

Ophthalmology. 2003 Jul;110(7):1321-6.

PMID:
12867385
17.

Reply: To PMID 23218706.

Browning DJ.

Am J Ophthalmol. 2013 Aug;156(2):410-1. doi: 10.1016/j.ajo.2013.04.011. No abstract available.

PMID:
23870364
18.

[Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].

Jaumouillé S, Espargillière D, Mouriaux F, Mortemousque B.

J Fr Ophtalmol. 2015 May;38(5):377-87. doi: 10.1016/j.jfo.2015.01.005. Epub 2015 Apr 24. French.

19.

A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.

Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB.

Retina. 2008 Nov-Dec;28(10):1478-86. doi: 10.1097/IAE.0b013e318181445b.

PMID:
18997610
20.

High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG.

Arch Ophthalmol. 2007 Jun;125(6):775-80.

Supplemental Content

Support Center